Nestlé announced on Tuesday the launch in the United States of a nutritional information platform aimed at patients taking anti-obesity drugs belonging to the GLP-1 class.

The site, which aims to offer a 'holistic' and 'personalized' approach for these individuals who must also follow a diet, aims to highlight its 'Garden of Life' (dietary supplements), 'Nature's Bounty' (vitamins and probiotics) and 'Boost' (nutritional supplements.

Users will also be able to benefit from the expertise of healthcare professionals in the fields of weight loss, as well as nutrition coaching and access to a community platform.

Nestlé says it intends to cover a wide range of topics such as muscle conservation, microbiota, micronutrient intake, hydration, skin and hair health, and controlling weight regain.

Copyright (c) 2024 CercleFinance.com. All rights reserved.